SVB Leerink Downgrades Innate Pharma S.A. (IPHA) to Market Perform

December 15, 2020 6:12 AM EST Send to a Friend
SVB Leerink analyst Daina Graybosch downgraded Innate Pharma S.A. (NASDAQ: IPHA) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login